« Return to News | Awards & Advancement

Medrio appoints execs from Genentech and NetSuite to board of directors

Thursday, November 15, 2012 08:00 AM

Medrio, a provider of advanced eClinical software as a service (SaaS) for clinical research, has made key appointments to its board of directors: Richard H. Scheller, executive vice president of research at Genentech, and Dave Lipscomb, founder and former executive at NetSuite.

Scheller is responsible for setting the strategy for Genentech’s research and drug discovery activities, is a member of Genentech’s executive committee, and is a member of the Roche Enlarged Corporate Executive Committee. Prior to joining Genentech, he served as professor of molecular and cellular physiology at Stanford University and as an investigator with the Howard Hughes Medical Institute.

Lipscomb brings great depth in software as a service (SaaS) to Medrio after spending 14 years at NetSuite since its inception in 1998. Holding the titles senior vice president of engineering, chief information officer and senior vice president of customer loyalty, he drove engineering, product management and IT operations. Prior to joining NetSuite, Lipscomb founded mBED Software and was a director in Oracle’s New Media Division. He has been building client/server and web server software products for 20 years.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.